These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
362 related articles for article (PubMed ID: 25292031)
1. Five miRNAs as novel diagnostic biomarker candidates for primary nasopharyngeal carcinoma. Tang JF; Yu ZH; Liu T; Lin ZY; Wang YH; Yang LW; He HJ; Cao J; Huang HL; Liu G Asian Pac J Cancer Prev; 2014; 15(18):7575-81. PubMed ID: 25292031 [TBL] [Abstract][Full Text] [Related]
2. Identification of a 7-microRNA signature in plasma as promising biomarker for nasopharyngeal carcinoma detection. Zhang H; Zou X; Wu L; Zhang S; Wang T; Liu P; Zhu W; Zhu J Cancer Med; 2020 Feb; 9(3):1230-1241. PubMed ID: 31856390 [TBL] [Abstract][Full Text] [Related]
3. miRNAs derived from circulating small extracellular vesicles as diagnostic biomarkers for nasopharyngeal carcinoma. Jiang L; Zhang Y; Li B; Kang M; Yang Z; Lin C; Hu K; Wei Z; Xu M; Mi J; Wang R; Wu F Cancer Sci; 2021 Jun; 112(6):2393-2404. PubMed ID: 33728743 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA expression profiling analysis in serum for nasopharyngeal carcinoma diagnosis. Zou X; Zhu D; Zhang H; Zhang S; Zhou X; He X; Zhu J; Zhu W Gene; 2020 Feb; 727():144243. PubMed ID: 31743768 [TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus mir-bart1-5p detection via nasopharyngeal brush sampling is effective for diagnosing nasopharyngeal carcinoma. Zheng XH; Lu LX; Cui C; Chen MY; Li XZ; Jia WH Oncotarget; 2016 Jan; 7(4):4972-80. PubMed ID: 26701721 [TBL] [Abstract][Full Text] [Related]
6. miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma. Luo Z; Dai Y; Zhang L; Jiang C; Li Z; Yang J; McCarthy JB; She X; Zhang W; Ma J; Xiong W; Wu M; Lu J; Li X; Li X; Xiang J; Li G Carcinogenesis; 2013 Feb; 34(2):415-25. PubMed ID: 23097559 [TBL] [Abstract][Full Text] [Related]
7. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer. Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145 [TBL] [Abstract][Full Text] [Related]
8. Plasma microRNA profiling in nasopharyngeal carcinoma patients reveals miR-548q and miR-483-5p as potential biomarkers. Zheng XH; Cui C; Ruan HL; Xue WQ; Zhang SD; Hu YZ; Zhou XX; Jia WH Chin J Cancer; 2014 Jul; 33(7):330-8. PubMed ID: 24874644 [TBL] [Abstract][Full Text] [Related]
9. A four-miRNA signature identified from genome-wide serum miRNA profiling predicts survival in patients with nasopharyngeal carcinoma. Liu N; Cui RX; Sun Y; Guo R; Mao YP; Tang LL; Jiang W; Liu X; Cheng YK; He QM; Cho WC; Liu LZ; Li L; Ma J Int J Cancer; 2014 Mar; 134(6):1359-68. PubMed ID: 23999999 [TBL] [Abstract][Full Text] [Related]
10. Circulating Epstein-Barr virus microRNAs miR-BART7 and miR-BART13 as biomarkers for nasopharyngeal carcinoma diagnosis and treatment. Zhang G; Zong J; Lin S; Verhoeven RJ; Tong S; Chen Y; Ji M; Cheng W; Tsao SW; Lung M; Pan J; Chen H Int J Cancer; 2015 Mar; 136(5):E301-12. PubMed ID: 25213622 [TBL] [Abstract][Full Text] [Related]
11. Identification and functional characterization of microRNAs reveal a potential role in gastric cancer progression. Li CY; Liang GY; Yao WZ; Sui J; Shen X; Zhang YQ; Peng H; Hong WW; Ye YC; Zhang ZY; Zhang WH; Yin LH; Pu YP Clin Transl Oncol; 2017 Feb; 19(2):162-172. PubMed ID: 27173517 [TBL] [Abstract][Full Text] [Related]
12. Circulating miR-31-5p may be a potential diagnostic biomarker in nasopharyngeal carcinoma. Yi SJ; Liu P; Chen BL; Ou-Yang L; Xiong WM; Su JP Neoplasma; 2019 Sep; 66(5):825-829. PubMed ID: 31129965 [TBL] [Abstract][Full Text] [Related]
13. H19/miR-675-5p Targeting SFN Enhances the Invasion and Metastasis of Nasalpharyngeal Cancer Cells. Zhang T; Lei F; Jiang T; Xie L; Huang P; Li P; Huang Y; Tang X; Gong J; Lin Y; Cheng A; Huang W Curr Mol Pharmacol; 2019; 12(4):324-333. PubMed ID: 31677258 [TBL] [Abstract][Full Text] [Related]
14. Five serum-based miRNAs were identified as potential diagnostic biomarkers in gastric cardia adenocarcinoma. Wang J; Zhang H; Zhou X; Wang T; Zhang J; Zhu W; Zhu H; Cheng W Cancer Biomark; 2018; 23(2):193-203. PubMed ID: 30198863 [TBL] [Abstract][Full Text] [Related]
15. A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis. Zhang H; Zhu M; Shan X; Zhou X; Wang T; Zhang J; Tao J; Cheng W; Chen G; Li J; Liu P; Wang Q; Zhu W Gene; 2019 Mar; 687():246-254. PubMed ID: 30458288 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-129-5p suppresses nasopharyngeal carcinoma lymphangiogenesis and lymph node metastasis by targeting ZIC2. Yu D; Han GH; Zhao X; Liu X; Xue K; Wang D; Xu CB Cell Oncol (Dordr); 2020 Apr; 43(2):249-261. PubMed ID: 31884576 [TBL] [Abstract][Full Text] [Related]
17. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling. Zhang K; Wang YW; Wang YY; Song Y; Zhu J; Si PC; Ma R Gene; 2017 Jul; 619():10-20. PubMed ID: 28359916 [TBL] [Abstract][Full Text] [Related]
18. Identification of miRNA/mRNA-Negative Regulation Pairs in Nasopharyngeal Carcinoma. Liu M; Zhu K; Qian X; Li W Med Sci Monit; 2016 Jun; 22():2215-34. PubMed ID: 27350400 [TBL] [Abstract][Full Text] [Related]
19. Identification of non-invasive biomarkers for predicting the radiosensitivity of nasopharyngeal carcinoma from serum microRNAs. Li K; Zhu X; Li L; Ning R; Liang Z; Zeng F; Su F; Huang S; Yang X; Qu S Sci Rep; 2020 Mar; 10(1):5161. PubMed ID: 32198434 [TBL] [Abstract][Full Text] [Related]
20. microRNA expression profiling of nasopharyngeal carcinoma. Li T; Chen JX; Fu XP; Yang S; Zhang Z; Chen KhH; Li Y Oncol Rep; 2011 May; 25(5):1353-63. PubMed ID: 21373758 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]